Cargando…

Correction to: Regdanvimab: First Approval

Detalles Bibliográficos
Autor principal: Syed, Yahiya Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895058/
https://www.ncbi.nlm.nih.gov/pubmed/34784016
http://dx.doi.org/10.1007/s40265-021-01641-8
_version_ 1784662825757573120
author Syed, Yahiya Y.
author_facet Syed, Yahiya Y.
author_sort Syed, Yahiya Y.
collection PubMed
description
format Online
Article
Text
id pubmed-8895058
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88950582022-03-04 Correction to: Regdanvimab: First Approval Syed, Yahiya Y. Drugs Correction Springer International Publishing 2021-11-16 2021 /pmc/articles/PMC8895058/ /pubmed/34784016 http://dx.doi.org/10.1007/s40265-021-01641-8 Text en © Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correction
Syed, Yahiya Y.
Correction to: Regdanvimab: First Approval
title Correction to: Regdanvimab: First Approval
title_full Correction to: Regdanvimab: First Approval
title_fullStr Correction to: Regdanvimab: First Approval
title_full_unstemmed Correction to: Regdanvimab: First Approval
title_short Correction to: Regdanvimab: First Approval
title_sort correction to: regdanvimab: first approval
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895058/
https://www.ncbi.nlm.nih.gov/pubmed/34784016
http://dx.doi.org/10.1007/s40265-021-01641-8
work_keys_str_mv AT syedyahiyay correctiontoregdanvimabfirstapproval